Nonin Medical, a leading innovator of physiological monitoring solutions, has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain – cerebral oximetry.

Duke University Medical Center, early testing data and outcomes from an ongoing clinical study yielded favourable results. These results  support the objective to simplify sensor application while improving the usefulness of the measurement.

Since 20years, Nonin Medical has remained at the forefront of noninvasive physiological monitoring with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx®, the world’s first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Now,  Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

GaryTschautscher, CEO and President of Nonin Medical said, This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again.  We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions.

Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives.

Tschautscher said, We must leave the old business models of protectionism behind. The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems.